首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Endothelial Dysfunction in Chronic Heart Failure: Assessment Findings Significance and Potential Therapeutic Targets
【2h】

Endothelial Dysfunction in Chronic Heart Failure: Assessment Findings Significance and Potential Therapeutic Targets

机译:慢性心力衰竭的内皮功能障碍:评估发现意义和潜在的治疗目标。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic heart failure (CHF) is a complex syndrome that results from structural and functional disturbances that affect the ability of the heart to supply oxygen to tissues. It largely affects and reduces the patient’s quality of life, socio-economic status, and imposes great costs on health care systems worldwide. Endothelial dysfunction (ED) is a newly discovered phenomenon that contributes greatly to the pathophysiology of numerous cardiovascular conditions and commonly co-exists with chronic heart failure. However, the literature lacks clarity as to which heart failure patients might be affected, its significance in CHF patients, and its reversibility with pharmacological and non-pharmacological means. This review will emphasize all these points and summarize them for future researchers interested in vascular pathophysiology in this particular patient population. It will help to direct future studies for better characterization of these two phenomena for the potential discovery of therapeutic targets that might reduce future morbidity and mortality in this “at risk” population.
机译:慢性心力衰竭(CHF)是一种复杂的综合症,是由于结构和功能紊乱引起的,这些紊乱影响心脏向组织供氧的能力。它在很大程度上影响并降低了患者的生活质量,社会经济地位,并给全球医疗保健系统带来了沉重的成本。内皮功能障碍(ED)是一种新发现的现象,对许多心血管疾病的病理生理有很大贡献,通常与慢性心力衰竭并存。但是,有关哪些心力衰竭患者可能受到影响,其在CHF患者中的意义以及其与药理学和非药理学方法的可逆性,文献缺乏明确性。这篇综述将强调所有这些要点,并将其总结给对特定患者人群中的血管病理生理学感兴趣的未来研究人员。这将有助于指导未来的研究,以更好地表征这两种现象,从而有可能发现治疗靶标,从而可能降低这一“高风险”人群的未来发病率和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号